908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire (Tue, 2-Jun 4:30 PM ET)
Major Stakeholder Makes Bold Exit Move in 908 Devices
TipRanks (Fri, 29-May 10:11 PM ET)
908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
Business Wire (Thu, 28-May 7:00 AM ET)
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
Business Wire (Wed, 6-May 7:30 AM ET)
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
Business Wire (Wed, 6-May 7:00 AM ET)
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
Business Wire (Fri, 1-May 8:30 AM ET)
Business Wire (Tue, 21-Apr 5:00 PM ET)
908 Devices to Present at the Sidoti Small Cap Conference
Business Wire (Mon, 16-Mar 7:00 AM ET)
Business Wire (Tue, 3-Mar 7:00 AM ET)
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
908 Devices trades on the NASDAQ stock market under the symbol MASS.
As of June 3, 2026, MASS stock price declined to $8.66 with 271,265 million shares trading.
MASS has a beta of 2.34, meaning it tends to be more sensitive to market movements. MASS has a correlation of 0.13 to the broad based SPY ETF.
MASS has a market cap of $327.47 million. This is considered a Small Cap stock.
Last quarter 908 Devices reported $13 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $219,600 and missed earnings estimates by -$.18.
In the last 3 years, MASS traded as high as $12.51 and as low as $1.81.
The top ETF exchange traded funds that MASS belongs to (by Net Assets): ARKG, IWM, VTI, VXF, IWO.
MASS has outperformed the market in the last year with a price return of +45.5% while the SPY ETF gained +28.5%. MASS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +31.0% and +27.7%, respectively, while the SPY returned +10.1% and +2.8%, respectively.
MASS support price is $8.46 and resistance is $9.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MASS shares will trade within this expected range on the day.